Aikido Pharma Inc. (AIKI)

Trade AIKI now with
6/10/2022 4:24:07 PM AIkido Pharma Appoints Soo Yu As Director
6/3/2022 4:41:29 PM AIkido Announces Reverse Stock Split
5/5/2022 9:48:04 AM AIkido Pharma Reports Slinger Bag's Filing For Nasdaq Public Listing
4/22/2022 10:02:20 AM Glass Lewis Recommends "FOR" AIkido Pharma Proposed Reverse Stock Split
9/28/2021 10:46:08 AM AIkido Pharma Secures Equity Interest In Tevva Motors
8/6/2021 10:02:11 AM AIkido Updates On Use Of Machine Learning In Drug Development Program
7/16/2021 10:17:06 AM AIkido Says Scientists Identified 4 Lead Compounds That Block Influenza, Coronavirus, And Ebolavirus Replication
6/23/2021 10:03:16 AM AIkido Files Patent Application For Use Of Ketamine To Treat Alzheimer's Disease
5/20/2021 9:38:42 AM AIkido Pharma : Phase 1 Data To Be Presented At American Society Of Clinical Oncology Annual Meeting
5/11/2021 9:06:18 AM AIkido Pharma Reports Cash Balance Of $102 Mln Or About $1.15 Per Share As Of March 31st
4/26/2021 9:07:14 AM AIkido Pharma Names Matthew Frieman Scientific Advisory Board
4/22/2021 9:12:50 AM AIkido Pharma Announces Withdrawal Of S-1 Registration Statement
4/7/2021 9:08:40 AM AIkido Secures Sublicense To Technology For Targeted Psilocybin Treatment Of Neuro-Inflamed Tissue In Cancer Patients
4/5/2021 9:06:08 AM AIkido Pharma Says Sufficiently Capitalized To Support Current Efforts And To Pursue Additional Emerging Opportunities
2/19/2021 11:16:33 AM AIkido Pharma Announces Closing Of $75 Mln Bought Deal Offering Of Common Stock
2/16/2021 10:16:18 PM AIkido Pharma Increases Bought Deal Offering Of Common Stock To $75 Mln
2/16/2021 8:38:55 AM AIkido Pharma Enters Into LoI With Silo Pharma For Use Of Psilocybin And Peptide Therapy For Cancer Treatment